MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest and dividend
income
$223,815
Net loss and
comprehensive loss
-$13,237,362
Total other income
$223,815
Loss from operations
-$13,461,177
Total operating
expenses
$13,461,177
General and
administrative expenses
$9,354,135
Research and development
expenses
$4,100,168
Depreciation expense
$6,874
Back
Back
Income Statement
source: myfinsight.com
Cadrenal Therapeutics, Inc. (CVKD)
Cadrenal Therapeutics, Inc. (CVKD)